Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Atlanta Cancer Care
mi
from
Atlanta, GA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Atlanta Cancer Care
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Augusta University
mi
from
Augusta, GA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Kaiser Permanente Hawaii - Moanalua Med Center
mi
from
Honolulu, HI
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Kaiser Permanente Hawaii - Moanalua Med Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of Chicago
mi
from
Chicago, IL
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Northwestern University - Robert H Lurie Comprehensive Cancer Center
mi
from
Chicago, IL
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Northwestern University - Robert H Lurie Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Rush University Medical Center
mi
from
Chicago, IL
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
North Shore University Health System
mi
from
Evanston, IL
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
North Shore University Health System
mi
from
Evanston, IL
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Loyola University Medical Center
mi
from
Maywood, IL
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Covenant Clinic / Iowa Spine and Brain Institute
mi
from
Waterloo, IA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Covenant Clinic / Iowa Spine and Brain Institute
mi
from
Waterloo, IA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of Kentucky
mi
from
Lexington, KY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Norton Cancer Institute
mi
from
Louisville, KY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Norton Cancer Institute
mi
from
Louisville, KY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Mary Bird Perkins Cancer Center
mi
from
Baton Rouge, LA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Mary Bird Perkins Cancer Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
LSU Health Sciences Center, Feist-Weiller Cancer Center
mi
from
Shreveport, LA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
LSU Health Sciences Center, Feist-Weiller Cancer Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Anne Arundel Medical Center
mi
from
Annapolis, MD
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Anne Arundel Medical Center
mi
from
Annapolis, MD
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Dana-Farber Cancer Institute and Mass General Hospital
mi
from
Boston, MA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Dana-Farber Cancer Institute and Mass General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of Michigan Health System
mi
from
Ann Arbor, MI
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Edward W. Sparrow Hospital Association - Sparrow Regional Cancer Center
mi
from
Lansing, MI
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Edward W. Sparrow Hospital Association - Sparrow Regional Cancer Center
mi
from
Lansing, MI
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
St. Mary's of Michigan Medical Center/Field Neurosciences Institute
mi
from
Saginaw, MI
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
St. Mary's of Michigan Medical Center/Field Neurosciences Institute
mi
from
Saginaw, MI
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Allina Health, Abbott Northwestern Hospital, John Nasseff Neuroscience Institute
mi
from
Minneapolis, MN
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Allina Health, Abbott Northwestern Hospital, John Nasseff Neuroscience Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Ellis Fischel Cancer Center
mi
from
Columbia, MO
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Ellis Fischel Cancer Center
mi
from
Columbia, MO
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Southeast Nebraska Cancer Center
mi
from
Lincoln, NE
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Southeast Nebraska Cancer Center
mi
from
Lincoln, NE
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
New Jersey Neuroscience Institute, JFK Medical Center
mi
from
Edison, NJ
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
New Jersey Neuroscience Institute, JFK Medical Center
mi
from
Edison, NJ
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Monmouth Medical Center
mi
from
Long Branch, NJ
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Monmouth Medical Center
mi
from
Long Branch, NJ
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Dent Neurosciences Research Institute
mi
from
Amherst, NY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Dent Neurosciences Research Institute
mi
from
Amherst, NY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Montefiore Medical Center
mi
from
Bronx, NY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
New York Methodist Hospital
mi
from
Brooklyn, NY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
New York Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
The Long Island Brain Tumor Center at Neurology Surgery, P.C.
mi
from
Great Neck, NY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
The Long Island Brain Tumor Center at Neurology Surgery, P.C.
mi
from
Great Neck, NY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
North Shore University Hospital
mi
from
Manhasset, NY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Columbia University Medical Center - The Neurologic Institute of New York
mi
from
New York, NY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Columbia University Medical Center - The Neurologic Institute of New York
mi
from
New York, NY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Univ of Rochester Medical Center
mi
from
Rochester, NY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Brain and Spine Surgeons of New York
mi
from
White Plains, NY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Brain and Spine Surgeons of New York
mi
from
White Plains, NY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Preston Robert Tisch Brain Tumor Center at Duke University Medical Center
mi
from
Durham, NC
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Preston Robert Tisch Brain Tumor Center at Duke University Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of Cincinnati Cancer Institute
mi
from
Cincinnati, OH
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of Cincinnati Cancer Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University Hospitals, Case Medical Center (Cleveland)
mi
from
Cleveland, OH
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University Hospitals, Case Medical Center (Cleveland)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Ohio State University
mi
from
Columbus, OH
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Providence Portland Medical Center, Oncology & Hematology Care
mi
from
Portland, OR
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Providence Portland Medical Center, Oncology & Hematology Care
mi
from
Portland, OR
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Pacific Neurosurgical
mi
from
Portland, OR
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Pacific Neurosurgical
mi
from
Portland, OR
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Lehigh Valley Physician Group-Hematology-Oncology Associates
mi
from
Allentown, PA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Lehigh Valley Physician Group-Hematology-Oncology Associates
mi
from
Allentown, PA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Temple University Hospital
mi
from
Philadelphia, PA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Medical University of South Carolina - Department of Neuroscience
mi
from
Charleston, SC
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Medical University of South Carolina - Department of Neuroscience
mi
from
Charleston, SC
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of Tennessee Medical Center at Knoxville
mi
from
Knoxville, TN
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of Tennessee Medical Center at Knoxville
mi
from
Knoxville, TN
Click here to add this to my saved trials